Evaluation of onset time and duration of Rocuronium in differet doses when used with Magnesium Sulfate

Phase 4

• Conditions: Aspiration pneumonia, neuromuscular nondepolarizing agents, intratracheal intubation; C08.381.677.529; D27.505.696.663.700.710.575; E02.041.500

• Registration Number: RBR-96cy3k
• Lead Sponsor: Hospital Universitário Cassiano Antônio de Moraes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-09
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients of aged 18 to 65 years; both gender; ASA physical status I or II; body mass index (BMI) between 18 and 27; with general anesthesia indication under tracheal intubation and controlled mechanical ventilation for elective surgical procedures indicating use of muscle relaxant.

Exclusion Criteria

Use drugs that can influence neuromuscular blockade (as phenytoin and aminoglycosides); hepatic, renal ou cardiac impairment; neuromuscular disease; predictability of difficulty in ventilation by mask or intubation; risk or confirmation of pregnancy; patients with inadequate preoperative fasting or at risk of pulmonary aspiration; electrolyte disorders, use magnesium supplementation; other contraindications to the use of parenteral magnesium; surgery associated with massive bleeding or high volume replacements; patients that develop electrolyte or acid-base disturbance, hypothermia or any other intraoperative condition that interferes with neuromuscular blockade

Study & Design

• Study Type: Intervention
• Study Design: Not specified